What is Chartspan Medical Technologies?
Chartspan Medical Technologies is recognized as the leading Chronic Care Management company in the United States. The firm provides comprehensive value-based care solutions designed to support both healthcare providers and their patient populations. By focusing on effective chronic condition management, Chartspan aims to improve patient outcomes and optimize healthcare delivery, aligning with the growing trend towards value-based reimbursement models in the industry.
How much funding has Chartspan Medical Technologies raised?
Chartspan Medical Technologies has raised a total of $88.6M across 7 funding rounds:
Other Financing Round
$250K
Angel/Seed
$1M
Private Equity
$1.7M
Private Equity
$3.2M
Private Equity
$16M
Series A
$15M
Debt
$1M
Other Financing Round (2013): $250K with participation from Don Byrne
Angel/Seed (2014): $1M led by Don Byrne
Private Equity (2015): $1.7M supported by Don Byrne
Private Equity (2016): $3.2M, investors not publicly disclosed
Private Equity (2017): $16M backed by Cypress Growth Capital
Series A (2019): $15M, investors not publicly disclosed
Debt (2020): $1M led by PPP
Key Investors in Chartspan Medical Technologies
Cypress Growth Capital
Cypress Growth Capital is a venture capital firm specializing in providing royalty-based funding, offering flexible and non-dilutive growth capital tailored for emerging companies, particularly in the SaaS and tech-enabled services sectors. Their funding model allows businesses to retain equity while accessing necessary capital, with payments adjusting based on revenue performance.
Don Byrne
Don Byrne has been an early and consistent supporter of Chartspan Medical Technologies, participating in multiple funding rounds from its initial stages through significant growth phases, indicating a strong belief in the company's long-term vision and market potential.
PPP
Public-Private Partnership
What's next for Chartspan Medical Technologies?
The recent major strategic investment in Chartspan Medical Technologies signals a pivotal moment for the company, likely enabling further scaling of its operations and expansion of its service offerings. This capital infusion is expected to fuel innovation in its chronic care management platform and potentially broaden its market reach. As a key player in the evolving healthcare landscape, Chartspan is well-positioned to leverage this financial backing to enhance its value-based care solutions and solidify its leadership in the chronic care management space.
See full Chartspan Medical Technologies company page
